Quality of life and neuropsychiatric disorders in patients with Graves' Orbitopathy: Current concepts
A Bruscolini, M Sacchetti, M La Cava, M Nebbioso… - Autoimmunity …, 2018 - Elsevier
Graves' disease (GD) is an autoimmune chronic thyroiditis frequently associated with
development of Graves' orbitopathy (GO) characterized by proptosis, strabismus, impairment …
development of Graves' orbitopathy (GO) characterized by proptosis, strabismus, impairment …
Psychological implications of Graves' orbitopathy
I Coulter, S Frewin, GE Krassas… - European Journal of …, 2007 - academic.oup.com
Patients with thyroid eye disease, Graves' orbitopathy (GO), often appear distressed and it is
likely that features of the condition such as disturbances in visual function, orbital discomfort …
likely that features of the condition such as disturbances in visual function, orbital discomfort …
[HTML][HTML] Predictive factors for changes in quality of life after steroid treatment for active moderate-to-severe Graves' orbitopathy: a prospective trial
E Hoppe, ACH Lee, D Hoppe… - European Thyroid …, 2021 - etj.bioscientifica.com
Objectives: To investigate the predictive factors for changes in the quality of life (GO-QoL) of
patients with Graves' orbitopathy (GO) prior to and after specific treatment. Methods: A …
patients with Graves' orbitopathy (GO) prior to and after specific treatment. Methods: A …
Prevalence and natural history of Graves' orbitopathy in the XXI century
E Piantanida, ML Tanda, A Lai, L Sassi… - Journal of …, 2013 - Springer
Graves' orbitopathy (GO) is an autoimmune disorder and the main extrathyroidal expression
of Graves' disease. There is a spectrum of ocular involvement in Graves' disease, from …
of Graves' disease. There is a spectrum of ocular involvement in Graves' disease, from …
Pathogenesis of Graves' orbitopathy: a 2010 update
TJ Smith - Journal of endocrinological investigation, 2010 - Springer
The most important of the extra-thyroidal manifestations of Graves' disease, Graves'
orbitopathy (GO), remains a vexing clinical problem. Treatment of severe active disease has …
orbitopathy (GO), remains a vexing clinical problem. Treatment of severe active disease has …
Evaluating graves' orbitopathy
PJ Dolman - Best Practice & Research Clinical Endocrinology & …, 2012 - Elsevier
Graves' Orbitopathy (GO) is an immune-mediated disorder causing inflammation and
expansion of orbital fat and muscle. The resulting spectrum of ocular and orbital changes …
expansion of orbital fat and muscle. The resulting spectrum of ocular and orbital changes …
Psychosocial morbidity of Graves' orbitopathy
GJ Kahaly, F Petrak, J Hardt, S Pitz… - Clinical …, 2005 - Wiley Online Library
Objective Ocular diseases markedly impair daily function. In Graves' orbitopathy (GO), an
associated psychosocial burden is present due to disfiguring proptosis and/or diplopia …
associated psychosocial burden is present due to disfiguring proptosis and/or diplopia …
The relationship between quality of life, cognition, and thyroid status in Graves' disease
CM Riguetto, AM Neto, MA Tambascia… - Endocrine, 2019 - Springer
Purpose To assess quality of life (QoL) and cognitive function among Graves' disease (GD)
patients with different thyroid status, with and without ophthalmopathy. Methods This is a …
patients with different thyroid status, with and without ophthalmopathy. Methods This is a …
Orbital diseases mimicking graves' orbitopathy: a long-standing challenge in differential diagnosis
M Marinò, I Ionni, G Lanzolla, A Sframeli… - Journal of …, 2020 - Springer
Graves' orbitopathy (GO) is the most common cause of orbital tissue inflammation,
accounting for~ 60% of all orbital inflammatory conditions in the population aged 21–60 …
accounting for~ 60% of all orbital inflammatory conditions in the population aged 21–60 …
Role of the underlying thyroid disease on the phenotype of Graves' orbitopathy in a tertiary referral center
M Leo, F Menconi, R Rocchi, F Latrofa, E Sisti… - Thyroid, 2015 - liebertpub.com
Background: Clinically overt Graves' orbitopathy (GO) is associated with Graves' disease
(GD) in approximately 95% of cases, whereas the remaining 5% is observed in patients with …
(GD) in approximately 95% of cases, whereas the remaining 5% is observed in patients with …